These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32668400)

  • 1. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).
    Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A
    Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).
    Singh A; Shaikh A; Singh R; Singh AK
    Diabetes Metab Syndr; 2020; 14(5):865. PubMed ID: 32562863
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)".
    Kumar Singh A; Singh R
    Diabetes Metab Syndr; 2020; 14(5):937-938. PubMed ID: 32593934
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
    Singh AK; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(5):729. PubMed ID: 32473904
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
    Mahajan K; Gaur N
    Diabetes Metab Syndr; 2020; 14(5):723-724. PubMed ID: 32473902
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to editor in response to "COVID-19: From bench to bedside" by Singh A et al.
    Singh H; Prasad Dhibar D
    Diabetes Metab Syndr; 2020; 14(5):815-816. PubMed ID: 32540734
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'.
    Ghoshal S;
    Diabetes Metab Syndr; 2020; 14(5):1541. PubMed ID: 32947752
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.).
    Hussain A; do Vale Moreira NC
    Diabetes Metab Syndr; 2020; 14(4):363. PubMed ID: 32325393
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of diabetes in patients with COVID-19 - Authors' reply.
    Bornstein SR; Zimmet P; Rubino F; Ludwig B
    Lancet Diabetes Endocrinol; 2020 Aug; 8(8):669-670. PubMed ID: 32707113
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
    Cai Q; Chen J; Xu L
    Diabetes Care; 2020 Oct; 43(10):e162. PubMed ID: 32958625
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter].
    Cariou B; Hadjadj S; Wargny M; Pichelin M; Al-Salameh A; Allix I; Amadou C; Arnault G; Baudoux F; Bauduceau B; Borot S; Bourgeon-Ghittori M; Bourron O; Boutoille D; Cazenave-Roblot F; Chaumeil C; Cosson E; Coudol S; Darmon P; Disse E; Ducet-Boiffard A; Gaborit B; Joubert M; Kerlan V; Laviolle B; Marchand L; Meyer L; Potier L; Prevost G; Riveline JP; Robert R; Saulnier PJ; Sultan A; Thébaut JF; Thivolet C; Tramunt B; Vatier C; Roussel R; Gautier JF; Gourdy P;
    Diabetologia; 2020 Nov; 63(11):2491-2494. PubMed ID: 32816095
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
    He Z; Li J
    Diabetes Care; 2020 Oct; 43(10):e160-e161. PubMed ID: 32958624
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
    Klonoff DC; Umpierrez GE
    Metabolism; 2020 Jul; 108():154224. PubMed ID: 32275971
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".
    Kokic Males V
    Diabetes Res Clin Pract; 2020 May; 163():108163. PubMed ID: 32333972
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407.
    Chen Y; Yang D; Yang C; Zheng L; Huang K
    Diabetes Care; 2020 Oct; 43(10):e165-e166. PubMed ID: 32958627
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study (
    Kim SY; Kim KS
    Diabetes Metab J; 2020 Aug; 44(4):621-622. PubMed ID: 32856803
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407.
    Cariou B; Hadjadj S; Wargny M; Pichelin M; Gourdy P
    Diabetes Care; 2020 Oct; 43(10):e163-e164. PubMed ID: 32958626
    [No Abstract]   [Full Text] [Related]  

  • 18. The Critical Care Society of Southern Africa guidelines on the allocation of scarce critical care resources during the COVID-19 public health emergency in South Africa.
    Gopalan PD; Joubert IA; Paruk F; Baker D; Coetzee I; De Vasconcellos K; Dolo LM; Levy BL; Morrow BM; Nel JM; Omar S; Piercy JL; Siebert RS; Veldsman L; Singh JA; Moodley K
    S Afr Med J; 2020 Jun; 110(8):700-703. PubMed ID: 32880283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.
    Chee YJ; Ng SJH; Yeoh E
    Diabetes Res Clin Pract; 2020 Aug; 166():108305. PubMed ID: 32623039
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.).
    Singh H; Dhibar DP
    Diabetes Metab Syndr; 2020; 14(5):807. PubMed ID: 32535453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.